Nanosonics Limited (NNCSF)
OTCMKTS · Delayed Price · Currency is USD
2.548
+0.000 (0.01%)
At close: Jul 24, 2025

Nanosonics Company Description

Nanosonics Limited operates as an infection prevention company globally.

The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies.

Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform.

The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Nanosonics Limited
Nanosonics logo
CountryAustralia
Founded2000
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees466
CEOMichael Kavanagh

Contact Details

Address:
Building A
Macquarie Park, 2113
Australia
Phone61 2 8063 1600
Websitenanosonics.com.au

Stock Details

Ticker SymbolNNCSF
ExchangeOTCMKTS
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU000000NAN9
SIC Code3845

Key Executives

NamePosition
Michael C. Kavanagh BSc, M.B.A.Chief Executive Officer, President, MD and Executive Director
Jason BurrissChief Financial Officer
Rod Lopez M.B.A.Chief Operating Officer and Regional President for Asia Pacific
Derek Minihane BSEE, J.D.Chief Technology Officer
Sunny PillaiChief Information Officer
Jon Burdach Ph.D.Chief Medical Affairs and Scientific Officer
Matthew Carbines B.Com., L.L.B.General Counsel and Company Secretary
Matthew Lipscombe B.E., B.Sc., M.B.A.Chief Marketing Officer
Jodi Sampson M.A.I.C.D., M.B.A.Chief People and Culture Officer
Ken Shaw B.Sc.Regional President of United States, Canada and Latin America